Intermittent and continuous imatinib in a human GIST xenograft model carrying<i>KIT</i>exon 17 resistance mutation D816HMona-Elisabeth Revheim, Therese Seierstad, Heikki Joensuu et al.|Acta Oncologica|2013Cited by 15
Dynamic 18 F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma XenograftsAlexandr Kristian, Therese Seierstad, Line Brennhaug Nilsen et al.|Nuclear Medicine and Molecular Imaging|2013Cited by 8
Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer XenograftNirma Skrbo, Kristin Andersen, Thérese Sørlie et al.|PLoS ONE|2014Cited by 7